Search icon
Learn, Analyse & Invest
only with
Orca logoArrow icon
+91
Download Orca
orca play storeorca apple store
To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

Source Natural Foods and Herbal Supplements Ltd.

Source Natural Foods

0.00

0.00 (0.00)%

NSE

BSE

Subsidiaries

No Data Available

No Subsidiaries Data available

Management

1. Narayanan Narasimhan
Non Executive Director
2. Chandrakumar Laxminarayan Rathi
Non Executive Independent Director
3. Romila Sen
Non Executive Independent Director
4. Sturle Harald Pedersen
Non Executive Director
5. Arvind Varchaswi N
Managing Director
6. Puvan Sripathy
Non Executive Independent Director
7. Prasana Prabhu
Non Executive Independent Director
8. Tejagna Kashmira Katpitia
Executive Director
9. HG Harsha
Non Executive Independent Director
10. Jeewan Prakash Gupta
Non Executive Director
11. Yash Jain
Company Secretary & Compliance Officer
12. Darshna Patel
Non Executive Independent Director

Contact Information

Company Address

201 , I I Nd Floor , Sumeru Towers, #54/46 , 39th A Cross , 11th Main Road, Jayanagar 4th T Block
Bengaluru, Karnataka - 560041
www.source_natural.com
info@source_natural.com

Registrar

Venture Capital & Corporate Investments Ltd
Aurum, Door No 4-50/P-II/57/4F&5F Plot No 57, 4th & 5th Floors, Jayabheri Enclave Phase - II, Gachibowli(Old Address:12-10-167, MIG- 167,Bharat Nagar Colony, Hyderabad – 500018.)Phone: +91-40-23818475/6Fax : +91-40-23868024Email: info@vccili
Phone: 23818475,23868257,35164910
Email: investor.relations@vccipl.com
Website: www.vccipl.com

Company Profile

Inwinex Pharmaceuticals, incorporated in 1995, is engaged in the manufacture of pharmaceuticals. Earlier known as Inwinex Laboratories, it got its present name on March 2, 2007.

The company has been incurring losses for past couple of years on account of partial shutdown of the factory for renovation and inadequate working capital facilities. The factory, located at Hyderabad in Andhra Pradesh, has been completely shut down since April 12, 2006 due to inadequacy of working capital.

In 2000, company decided to hive-off the bulk drug unit and diversify into software related activities by changing the main clause. And in 2001, the company has signed an agreement with CDSL, NSDL and Venture Capital and Corporate Investment for dematerialization.

Business areas of the company:

The company manufactures antibiotics, norfloxacin, pefloxacin, enrofloxacin and electrolyte supplements.

Enrich money logo